On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its holdings in Certara Inc (NASDAQ:CERT), a key player in the biosimulation software and technology sector. This transaction had a negligible impact on Baillie Gifford (Trades, Portfolio)'s portfolio, with the trade executed at a price of $14.64 per share. Despite the reduction, Baillie Gifford (Trades, Portfolio) maintains a 5.58% position in Certara, reflecting a 0.12% ratio of the traded stock in the firm's overall portfolio.